论文信息 - Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer - 字舞流文

Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer

M. Burkard | J. Kolesar | J. Eickhoff | A. Tevaarwerk | K. Wisinski | M. Bell | Amye J. Tevaarwerk | Glenn Liu | M. Rampurwala | C. Flynn